Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Background The main advantage of GeneXpert MTB/RIF ® (Xpert) molecular diagnostic technology is the rapid detection of M .tuberculosis DNA and mutations associated with rifampicin (RIF) resistance for timely initiation of appropriate treatment and, consequently, preventing further transmission of th...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMC infectious diseases Ročník 20; číslo 1; s. 1 - 9
Hlavní autoři:	Ershova, Julia V., Volchenkov, Grigory V., Somova, Tatiana R., Kuznetsova, Tatiana A., Kaunetis, Natalia V., Kaminski, Dorothy, Demikhova, Olga V., Chernousova, Larisa N., Vasilyeva, Irina A., Kerr, Eleanor M., Cegielski, J. Peter, Kurbatova, Ekaterina V.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 25.07.2020 BioMed Central Ltd Springer Nature B.V BMC
Témata:	Clinical outcomes Diagnosis Diagnostic systems Disease transmission Drug resistance GeneXpert MTB/RIF Health services HIV Human immunodeficiency virus Imprisonment Infectious Diseases Internal Medicine Medical Microbiology Medical research Medicine Medicine & Public Health Mutation Parasitology Patient outcomes Patients Rank tests Research Article Rifampicin Rifampin Statistical analysis Survival analysis Tropical Medicine Tuberculosis Tuberculosis and other mycobacterial diseases Russia Drug resistance Rifampicin GeneXpert MTB/RIF
ISSN:	1471-2334, 1471-2334
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!